BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 28361503)

  • 21. Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.
    Marcus JL; Volk JE; Pinder J; Liu AY; Bacon O; Hare CB; Cohen SE
    Curr HIV/AIDS Rep; 2016 Apr; 13(2):116-24. PubMed ID: 26898645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
    Govender EM; Mansoor LE; Abdool Karim Q
    AIDS Care; 2017 Jun; 29(6):734-740. PubMed ID: 27799005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women - a qualitative study.
    Katirayi L; Chouraya C; Kudiabor K; Mahdi MA; Kieffer MP; Moland KM; Tylleskar T
    BMC Public Health; 2016 Oct; 16(1):1119. PubMed ID: 27776495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The future of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection.
    Özdener AE; Park TE; Kalabalik J; Gupta R
    Expert Rev Anti Infect Ther; 2017 May; 15(5):467-481. PubMed ID: 28322067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report.
    Hoornenborg E; Prins M; Achterbergh RCA; Woittiez LR; Cornelissen M; Jurriaans S; Kootstra NA; Anderson PL; Reiss P; de Vries HJC; Prins JM; de Bree GJ;
    Lancet HIV; 2017 Nov; 4(11):e522-e528. PubMed ID: 28919303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-exposure prophylaxis for HIV prevention during pregnancy and lactation: forget not the women and children.
    Horgan L; Blyth CC; Bowen AC; Nolan DA; McLean-Tooke AP
    Med J Aust; 2019 Apr; 210(6):281-284. PubMed ID: 30838677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advancing HIV prevention using tenofovir-based pre-exposure prophylaxis.
    Abdool Karim SS; Baxter C; Abdool Karim Q
    Antivir Ther; 2022 Apr; 27(2):13596535211067589. PubMed ID: 35499171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preexposure Prophylaxis For HIV Prevention: What We Know and What We Still Need to Know for Implementation.
    Landovitz RJ
    Top Antivir Med; 2015; 23(2):85-90. PubMed ID: 26200708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Family planning providers' role in offering PrEP to women.
    Seidman D; Weber S; Carlson K; Witt J
    Contraception; 2018 Jun; 97(6):467-470. PubMed ID: 29408284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early pre-exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa.
    Joseph Davey DL; Mvududu R; Mashele N; Lesosky M; Khadka N; Bekker LG; Gorbach P; Coates TJ; Myer L
    J Int AIDS Soc; 2022 Feb; 25(2):e25866. PubMed ID: 35138678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PrEP Implementation for Mothers in Antenatal Care (PrIMA): study protocol of a cluster randomised trial.
    Dettinger JC; Kinuthia J; Pintye J; Mwongeli N; Gómez L; Richardson BA; Barnabas R; Wagner AD; O'Malley G; Baeten JM; John-Stewart G
    BMJ Open; 2019 Mar; 9(3):e025122. PubMed ID: 30850409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of tenofovir-containing antiretroviral therapy in women who acquired HIV while enrolled in tenofovir gel prophylaxis trials.
    Naicker N; Naidoo A; Werner L; Garrett N; Majola N; Asari V; Baxter C; Grobler A; Karim QA; Karim SSA
    Antivir Ther; 2017; 22(4):287-293. PubMed ID: 27835613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding Retention in the HIV Pre-Exposure Prophylaxis Cascade Among Cisgender Women.
    Burns JA; Hull SJ; Inuwa A; Moriarty P; Scott RK
    AIDS Patient Care STDS; 2023 Apr; 37(4):205-211. PubMed ID: 36961388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perceptions of HIV Preexposure Prophylaxis Among Young Pregnant Women from Rural KwaZulu-Natal, South Africa.
    Vazquez L; Moll AP; Kacin A; Ndlovu NE; Shenoi SV
    AIDS Patient Care STDS; 2019 May; 33(5):214-219. PubMed ID: 31067125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of pre-exposure prophylaxis with on-demand tenofovir disoproxil fumarate/emtricitabine resulting in emergence of antiretroviral resistance.
    Hsiao YY; Huang YC; Chang SY; Kuo CH; Chang SF; Lin YT; Luo YZ; Lee YL; Hung CC
    J Microbiol Immunol Infect; 2021 Aug; 54(4):755-757. PubMed ID: 33597075
    [No Abstract]   [Full Text] [Related]  

  • 37. Barriers and facilitators to uptake and use of oral pre-exposure prophylaxis in pregnant and postpartum women: a qualitative meta-synthesis.
    Liu Y; Zhang L; Chen H
    BMC Public Health; 2024 Jun; 24(1):1653. PubMed ID: 38902766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial.
    Fonsart J; Saragosti S; Taouk M; Peytavin G; Bushman L; Charreau I; Hance A; Goldwirt L; Morel S; Mammano F; Loze B; Capitant C; Clavel F; Mahjoub N; Meyer L; Anderson PL; Delaugerre C; Molina JM
    J Antimicrob Chemother; 2017 Feb; 72(2):478-485. PubMed ID: 28073964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PURLs: On-demand pill protocol protects against HIV.
    Justesen K; Prasad S
    J Fam Pract; 2016 Aug; 65(8):556-8. PubMed ID: 27660840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1-infection in a man who has sex with men despite self-reported excellent adherence to pre-exposure prophylaxis, the Netherlands, August 2021: be alert to emtricitabine/tenofovir-resistant strain transmission.
    Koole JC; de la Court F; Welkers MR; Yap K; Stalenhoef JE; Jurriaans S; de Vries HJ; Op de Coul EL; Prins M; Hoornenborg E
    Euro Surveill; 2022 Apr; 27(14):. PubMed ID: 35393931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.